Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccine Therapy in Treating Patients With Kidney Cancer

This study has been terminated.
Information provided by (Responsible Party):
Caladrius Biosciences, Inc. Identifier:
First received: April 10, 2001
Last updated: May 25, 2016
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)